1-2 of 2
Marieke van de Ven
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB_B04: Deciphering FGFR3-TACC3 oncogenic fusions

Julia Yemelyanenko, Jinhyuk Bhin, Sjoerd Klarenbeek, Ji-Ying Song, Catrin Lutz, Marieke van de Ven, Shridar Ganesan, Lodewyk F. A. Wessels, Daniel Zingg, Jos Jonkers
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): LB_B04.
https://doi.org/10.1158/1535-7163.TARG-23-LB_B04
Published: 01 December 2023
View article titled, Abstract LB_B04: Deciphering FGFR3-TACC3 oncogenic fusions
Journal Articles

Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin

Remco Nagel, Ana Teresa Avelar, Nanne Aben, Natalie Proost, Marieke van de Ven, Jan van der Vliet, Miranda Cozijnsen, Hilda de Vries, Lodewyk F. A. Wessels, Anton Berns
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (4): 762–770.
https://doi.org/10.1158/1535-7163.MCT-18-0972
Published: 01 April 2019
View article titled, Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
Open the PDF for Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin in another window
Includes: Supplementary data